Disease | hyperuricemia |
Phenotype | C0376545|hematological malignancies |
Sentences | 2 |
PubMedID- 20818444 | Effectiveness of a single 3-mg rasburicase dose for the management of hyperuricemia in patients with hematological malignancies. |
PubMedID- 26161019 | Therefore, febuxostat and rasburicase may be good alternatives for the treatment of hyperuricemia, particularly in patients with hematological malignancies who are likely to undergo chemotherapy. |
Page: 1